Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167830 · ClinicalTrials.gov registry record · Phase 1
Barriers to Treatment in Obese Adolescents
A Phase 1 study of Obesity, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 292
- Enrollment target
- 1
- Study location
NCT00167830 is a Phase 1 study of Obesity that has completed, run by Virginia Commonwealth University. The registered enrollment target is 292 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00167830, a Phase 1 study of Obesity, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 292 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify significant racial and ethnical differences in risk factors for development of obesity and weight loss in adolescents in Central Virginia
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Strength and Cardiovascular Conditioning
- BEHAVIORAL Food selection and portion control
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2003-11 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167830
The ClinicalTrials.gov registry entry for NCT00167830 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (64% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Motivational Interviewing is the first listed.
NCT00167830 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00167830 about?
NCT00167830 is a clinical study titled "Barriers to Treatment in Obese Adolescents". The purpose of this study is to identify significant racial and ethnical differences in risk factors for development of obesity and weight loss in adolescents in Central Virginia
What is the current status of trial NCT00167830?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 292 participants. The study started on 2003-11. Estimated completion is 2013-12.
What conditions does trial NCT00167830 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00167830?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Strength and Cardiovascular Conditioning (BEHAVIORAL), Food selection and portion control (BEHAVIORAL).
Who is sponsoring clinical trial NCT00167830?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167830 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
RECRUITING · Phase 1
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
-
A Study of LY3971297 in Healthy Participants
RECRUITING · Phase 1
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.